The company described the round as fully subscribed and said the cash should keep operations running into the second half of ...
Life Biosciences Inc. closed on an $80 million financing that will fund the anti-aging company’s operations into the second ...
A startup cofounded by a renowned Harvard geneticist has taken a step toward cracking the human body’s biological breakdown by securing FDA approval to test its cutting-edge gene therapy on humans.
The first clinical attempt to make human beings biologically younger is no longer a thought experiment. A small gene therapy trial, cleared quietly by regulators in the United States, is now moving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results